The Trump administration signaled Medicare drug price negotiations under the Inflation Reduction Act (IRA) signed in 2022 by former President ... or beneficiary,” wrote Holz-Eakin in a blog post. “The ...

Spring has nearly sprung and round two of the Inflation Reduction Act (IRA)’s negotiation period has begun. | All of the ...

“The Trump campaign articulated no position on drug price negotiation ... the IRA in its entirety,” said Juliette Cubanski, deputy director of the program on Medicare policy at KFF, a health ...

Talks between CMS and drugmaker Amgen authorized under the Inflation Reduction Act (IRA), former President Biden's signature ...

The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug price negotiation program enacted under President Joe Biden.

Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations ... correct what they see as the biggest flaw in the IRA - the shorter window time for small molecule drugs ...

The negotiations are a key provision of Biden's Inflation Reduction Act, or IRA ... prices, Campbell said. Trump could also revise what Medicare considers one drug for the purpose of negotiations ...

As a drugmaker depending heavily on sales of both branded and non-branded products, Teva has said that it is uniquely affected by how medicines are selected for the Medicare drug price negotiation | ...

“IRA price negotiations and controls will lead to fewer life-saving drugs coming to market,” cautions Dr. Joel Zinberg, a special assistant to the president at the National Economic Counci ...

In August 2023, CMS identified the first 10 drugs for price negotiation. In August 2024, CMS announced the new prices for these drugs, which are slated to take effect in 2026. The pharmaceutical ...

The Centers for Medicare and Medicaid Services is moving forward with Medicare drug price negotiations under the Trump administration, although it said it is seeking to bring "greater transparency ...